摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N9-(6'-(N-(tert-butyloxycarbonyl)amino)-2',3'-O-isopropylidene-5',6',7',8',9'-pentadeoxy-β-D-ribo-1',4'-undecafuranosyl)adenine | 135285-34-6

中文名称
——
中文别名
——
英文名称
N9-(6'-(N-(tert-butyloxycarbonyl)amino)-2',3'-O-isopropylidene-5',6',7',8',9'-pentadeoxy-β-D-ribo-1',4'-undecafuranosyl)adenine
英文别名
tert-butyl N-[1-[(3aR,4R,6R,6aR)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]-6,7-dihydroxyheptan-2-yl]carbamate
N<sup>9</sup>-(6'-(N-(tert-butyloxycarbonyl)amino)-2',3'-O-isopropylidene-5',6',7',8',9'-pentadeoxy-β-D-ribo-1',4'-undecafuranosyl)adenine化学式
CAS
135285-34-6;135285-41-5;135285-43-7;135285-44-8
化学式
C24H38N6O7
mdl
——
分子量
522.602
InChiKey
FBEIQCPTVXYAJC-YYCZMQGOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.63
  • 重原子数:
    37.0
  • 可旋转键数:
    9.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    176.1
  • 氢给体数:
    4.0
  • 氢受体数:
    12.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N9-(6'-(N-(tert-butyloxycarbonyl)amino)-2',3'-O-isopropylidene-5',6',7',8',9'-pentadeoxy-β-D-ribo-1',4'-undecafuranosyl)adenine三氟乙酸 作用下, 以 为溶剂, 生成 (2R,3S,4R,5R)-2-((S)-2-Amino-6,7-dihydroxy-heptyl)-5-(6-amino-purin-9-yl)-tetrahydro-furan-3,4-diol
    参考文献:
    名称:
    Synthesis and biological activity of sinefungin analogs
    摘要:
    A series of nucleosides (2-4) that derive from adenosine by chain extension at the 5'-end have been synthesized starting from the known phosphonate 7. The latter was first combined with 4-pentenal to give 8, which underwent chemical manipulations to provide triacetate 11, which was found suitable for the adenylation step. Further transformations, among them the Hofmann degradation of the amide group of compound 13, and final deprotection gave nucleosides 2-4. They were considered as analogues of sinefungin (1) and tested for their antileishmanial activity together with compounds 5 and 6, which were obtained independently. All the modifications with respect to sinefungin resulted in nearly complete loss of growth inhibitory activity. These results indicate that the 9' terminal amino and carboxyl groups are necessary for the activity and that the presence of the amino group at C-6' is not sufficient to maintain the antileishmanial effect. Some of the analogues however could antagonize or reverse the inhibitory activity of sinefungin (1).
    DOI:
    10.1021/jm00113a018
  • 作为产物:
    描述:
    N9-(6'-(N-(tert-butyloxycarbonyl)amino)-10'-ene-5',6',7',8',9',10',11'-heptadeoxy-2',3'-O-isopropylidene-β-D-ribo-1',4'-undecafuranosyl)adenine四氧化锇N-甲基吗啉氧化物 作用下, 以 乙腈 为溶剂, 以70%的产率得到N9-(6'-(N-(tert-butyloxycarbonyl)amino)-2',3'-O-isopropylidene-5',6',7',8',9'-pentadeoxy-β-D-ribo-1',4'-undecafuranosyl)adenine
    参考文献:
    名称:
    Synthesis and biological activity of sinefungin analogs
    摘要:
    A series of nucleosides (2-4) that derive from adenosine by chain extension at the 5'-end have been synthesized starting from the known phosphonate 7. The latter was first combined with 4-pentenal to give 8, which underwent chemical manipulations to provide triacetate 11, which was found suitable for the adenylation step. Further transformations, among them the Hofmann degradation of the amide group of compound 13, and final deprotection gave nucleosides 2-4. They were considered as analogues of sinefungin (1) and tested for their antileishmanial activity together with compounds 5 and 6, which were obtained independently. All the modifications with respect to sinefungin resulted in nearly complete loss of growth inhibitory activity. These results indicate that the 9' terminal amino and carboxyl groups are necessary for the activity and that the presence of the amino group at C-6' is not sufficient to maintain the antileishmanial effect. Some of the analogues however could antagonize or reverse the inhibitory activity of sinefungin (1).
    DOI:
    10.1021/jm00113a018
点击查看最新优质反应信息